Bayer Raises Full-Year Guidance; Second-Quarter Net Income Declines

Bayer today reported a 34% decline in second-quarter net income to €494 million ($611.1 million), with strong second-quarter sales and underlying earnings growth. Sales rose 10%, to a reported record of €10.18 billion, with CropScience and HealthCare sustaining strong momentum and MaterialScience improving further earnings before interest and tax (EBIT). Net income was impacted by special items of €800 million, including risk provisions of €500 million for litigations. “In view of the strong business performance, we are raising our...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers